Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception|December 1, 1990
Clinical experience with a low-dose oral contraceptive containing gestodeneB Düsterberg, K Brill
American Journal of Obstetrics and Gynecology|October 1, 1990
Clinical acceptability of monophasic gestodeneB Düsterberg, K Brill
Therapeutische Umschau. Revue Therapeutique|December 1, 1990
[Clinical experiences with femovan (Gynera)]K Brill, B Düsterberg, M Albring
Steroids|January 1, 1984
Plasma levels of levonorgestrel, gestodene, norethisterone and cyproterone acetate on single-dose subcutaneous administration in oily solution in the rat, beagle and rhesus monkeyB Düsterberg
Contraception|April 1, 1984
Plasma levels and progestational activity of levonorgestrel after repeated intravenous and subcutaneous administration in the beagle bitchB Düsterberg, S Beier
Hormone Research|January 1, 1983
Plasma levels of dehydroepiandrosterone and 17 beta-estradiol after intramuscular administration of Gynodian-Depot in 3 womenB Düsterberg, H Wendt
Maturitas|December 1, 1982
Pharmacokinetic and pharmacological features of oestradiol valerateB Düsterberg, Y Nishino
Urologia Internationalis|January 1, 1980
[Bioavailability of cyproterone acetate after oral and intramuscular application in men (author's transl)]H Becker, B Düsterberg, H Klosterhalfen
Contraception|March 1, 1997
A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle control, and toleranceJ Endrikat, U Müller, B Düsterberg
Arzneimittel-Forschung|August 1, 1986
Half-lives in plasma and bioavailability of ethinylestradiol in laboratory animalsB Düsterberg, G Kühne, U Täuber
Pageof 8